Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy

NCT07173686 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07173686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
November 1, 2026
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy